Increased long-term mortality in patients with cardiovascular implantable electronic device infections

PACE - Pacing and Clinical Electrophysiology

Volumn 38, Issue 2, 2015, Pages 231-239

  Rizwan Sohail, Muhammad ^a   Henrikson, Charles A ^b   Jo Braid Forbes, Mary ^c   Forbes, Kevin F ^c,d   Lerner, Daniel J ^e  

^a MAYO CLINIC   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Braid Forbes Health Research   (United States)

^d CATHOLIC UNIVERSITY OF AMERICA   (United States)

^e Tyrx Inc   (United States)

Author keywords

cardiac resynchronization therapy; cardiovascular implantable electronic device; implantable cardioverter defibrillator; infection; mortality; pacemaker

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTEREMIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE; COHORT ANALYSIS; COMORBIDITY; DEATH; DEVICE INFECTION; DEVICE REMOVAL; DUAL CHAMBER PACEMAKER; ENDOCARDITIS; FEMALE; HUMAN; ICD-9-CM; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPTICEMIA; SINGLE CHAMBER PACEMAKER; TREATMENT OUTCOME; VERY ELDERLY; AGE DISTRIBUTION; EPIDEMIOLOGY; HEART FAILURE; INCIDENCE; INFECTION; LONGITUDINAL STUDY; MIDDLE AGED; RISK FACTOR; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED STATES;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 84922672842     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12518     Document Type: Article

References (16)

1. Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ,. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med 2011; 171: 1821-1828.
2. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 2011; 8: 1678-1685.
3. Habib A, Le KY, Baddour LM, Friedman PA, Hayes DL, Lohse CM, Wilson WR, et al. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol 2013; 111: 874-879.
4. Henrikson CA, Zhang K, Brinker JA,. High mid-term mortality following successful lead extraction for infection. Pacing Clin Electrophysiol 2011; 34: 32-36.
5. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Management and outcome of permanent pacemaker and implantable cardioverter defibrillator infections. J Am Coll Cardiol 2007; 49: 1851-1859.
6. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, et al. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010; 121: 458-477.
7. Elixhauser A, Steiner C, Harris DR, Coffey RM,. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
8. Southern DA, Quan H, Ghali WA,. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care 2004; 42: 355-360.
9. Li B, Evans D, Faris P, Dean S, Quan H,. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res 2008; 8: 1-7.
10. HCUP Comorbidity Software. Healthcare Cost and Utilization Project (HCUP). 2008 Rockville, MD, Agency for Healthcare Research and Quality. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp (accessed June 1, 2011).
11. Collett D,. Modelling Binary Data. Boca Raton, Chapman & Hall/CRC, 2003.
12. Hilbe J,. Negative Binomial Regression. Cambridge, MA, Cambridge University Press, 2007.
13. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, Fraser TG, et al. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes. Heart Rhythm 2010; 7: 1043-1047.
14. de Bie MK, van Rees JB, Thijssen J, Borleffs CJ, Trines SA, Cannegieter SC, Schalij MJ, et al. Cardiac device infections are associated with a significant mortality risk. Heart Rhythm 2012; 9: 494-498.
15. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J,. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29: 142-145.
16. Sohail MR, Hussain S, Le KY, Dib C, Lohse CM, Friedman PA, Hayes DL, et al. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol 2011; 31: 171-183.